To access this element change to forms mode OFF
Grant Award View - GA268496
- Compound repurposing into novel therapeutics to treat SARS-COV2...
GA ID:
GA268496
Agency:
Department of Health and Aged Care
Approval Date:
19-Jun-2022
Publish Date:
4-Oct-2022
Category:
Medical Research
Grant Term:
19-Jun-2022 to 31-May-2024
Value (AUD):
$998,520.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 21/22 1.1 Health Policy Research and Analysis
Grant Program:
MRFF Research Grants
Grant Activity:
- Compound repurposing into novel therapeutics to treat SARS-COV2 infection.
Purpose:
With continued SARS-CoV-2 mutant variants causing death, it is imperative that repurposed medicines be use clinically where possible. We have identified a number of approved safe compounds with acceptable safety profiles to test. Using our 3D organotypic cell model, we will identify those most beneficial. Treatment with these agents may prevent infection, transmission, stop the cytokine storm, prevent the need for hospitalization, and reduce the overall healthcare burden caused by SARS-CoV-2.
GO ID:
GO Title:
MRFF – CRR – 2021 COVID-19 Treatment Access and Public Health Activities Grant Opportunity
Internal Reference ID:
2022/MRF2016238
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Curtin University
Recipient ABN:
99 143 842 569
Grant Recipient Location
Suburb:
Bentley
Town/City:
Bentley
Postcode:
6102
State/Territory:
WA
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
WA
Postcode:
Country:
AUSTRALIA